September 06, 2025

Get In Touch

Higher Risk Of Stroke, MI And Death Post Retinal Artery Occlusion: JAMA

Retinal Artery Occlusion Study

Retinal Artery Occlusion (RAO)

Retinal artery occlusion (RAO) refers to blockage of the retinal artery carrying oxygen to the nerve cells in the retina at the back of the eye. The lack of oxygen delivery to the retina may result in severe loss of vision. Usually, patients are at higher risk if they are older or have high blood pressure, glaucoma, or diabetes.

A new study found an increased risk of subsequent death and vascular events, including stroke and myocardial infarction, in patients post-RAO compared with matched controls, although the risk was lower than previously reported within 1 month of an RAO diagnosis. The study is published in JAMA Ophthalmology. These results support awareness of potentially elevated risk of death, myocardial infarction, and stroke in patients after RAO, emphasizing that multidisciplinary evaluation and long-term follow-up should be considered for these patients.

Study Details

Researchers conducted a retrospective cohort study using aggregated electronic health records from January 1, 2003, through April 14, 2023, from TriNetX, a network with data from more than 111 million patients. Patients with RAO and a cataract control group were identified and matched for age, sex, race, and comorbidities, including hypertension, diabetes, hyperlipidemia, and smoking status. Patients were excluded if they had a stroke or MI within 2 years before the diagnosis of RAO or cataract. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, diagnosis code for RAO or age-related cataract. Rate of death, stroke, and MI at 2 weeks, 30 days, 1 year, 5 years, and 10 years after RAO compared with matched controls.

Key Findings

  • A total of 34,874 patients with at least 1 year of follow-up in the RAO cohort. The mean (SD) age at the RAO event was 66 (15.2) years.
  • The rate of death after RAO diagnosis was higher than after cataract diagnosis at:
    • 2 weeks (0.14% vs 0.06%)
    • 30 days (0.29% vs 0.14%)
    • 1 year (3.51% vs 1.99%)
    • 5 years (22.74% vs 17.82%)
    • 10 years (57.86% vs 55.38%)
  • Risk of stroke after RAO was higher at:
    • 2 weeks (1.72% vs 0.08%)
    • 30 days (2.48% vs 0.18%)
    • 1 year (5.89% vs 1.13%)
    • 5 years (10.85% vs 4.86%)
    • 10 years (14.59% vs 9.18%)
  • Risk of MI after RAO was higher at:
    • 2 weeks (0.16% vs 0.06%)
    • 30 days (0.27% vs 0.10%)
    • 1 year (1.66% vs 0.97%)
    • 5 years (6.06% vs 5.00%)
    • 10 years (10.55% vs 9.43%)

Researchers concluded that “This study showed an increased risk of death, stroke, and MI in patients with RAO at both short-term and long-term intervals after RAO compared with a matched control population diagnosed with cataract. These findings suggest a potential need for multidisciplinary evaluation and long-term systemic follow-up of patients post-RAO.”

Reference: Wai KM, Knapp A, Ludwig CA, et al. Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion. JAMA Ophthalmol. Published online October 26, 2023. doi:10.1001/jamaophthalmol.2023.4716.

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!